BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37986077)

  • 21. Poor prognosis of uterine serous carcinoma compared with grade 3 endometrioid carcinoma in early stage patients.
    Park JY; Nam JH; Kim YT; Kim YM; Kim JH; Kim DY; Sohn I; Lee SW; Sung CO; Kim KR
    Virchows Arch; 2013 Mar; 462(3):289-96. PubMed ID: 23417747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
    Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
    Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
    Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
    Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of management on the prognosis of pure uterine papillary serous cancer - a Taiwanese Gynecologic Oncology Group (TGOG) study.
    Huang CY; Tang YH; Chiang YC; Wang KL; Fu HC; Ke YM; Lau HY; Hsu KF; Wu CH; Cheng WF
    Gynecol Oncol; 2014 May; 133(2):221-8. PubMed ID: 24556064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
    Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
    Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinicopathological and survival analysis of 34 cases of uterine clear cell carcinoma].
    Zhang F; Deng LS; Li B; Huang MN; Li XG; Zhang R; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):345-350. PubMed ID: 33752316
    [No Abstract]   [Full Text] [Related]  

  • 27. Adjuvant chemotherapy in endometrial cancer.
    Gómez-Raposo C; Merino Salvador M; Aguayo Zamora C; Casado Saenz E
    Cancer Chemother Pharmacol; 2020 Mar; 85(3):477-486. PubMed ID: 31950214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry.
    Mattes MD; Lee JC; Metzger DJ; Ashamalla H; Katsoulakis E
    J Gynecol Oncol; 2015 Jan; 26(1):19-24. PubMed ID: 25310855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
    He Y; Wang Y; Ji C; Liu Y; Wu YM
    Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
    [No Abstract]   [Full Text] [Related]  

  • 30. [Endometrioid endometrial cancer--the prognostic value of selected clinical and pathological parameters].
    Gottwald L; Chałubińska J; Moszyńska-Zielińska M; Piekarski J; Tyliński W; Szwalski J; Kubiak R; Pasz-Walczak G; Hendzel K; Ciałkowska-Rysz A
    Ginekol Pol; 2011 Oct; 82(10):743-8. PubMed ID: 22379937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of adjuvant treatment for early-stage uterine clear cell carcinomas.
    Orellana TJ; Garrett AA; Soong TR; Rives T; Courtney-Brooks M; Taylor SE; Lesnock J; Berger J; Boisen M; Coffman L; Buckanovich R; Mahdi H; Comerci JC; Beriwal S; Sukumvanich P; Edwards RP; Bhargava R; Olawaiye AB
    Gynecol Oncol; 2023 Mar; 170():77-83. PubMed ID: 36641903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
    Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
    Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant Chemotherapy versus Radiotherapy in High-risk, Early-stage Endometrioid Endometrial Carcinoma.
    Wu M; Yang YN; Huang YH; Cai J; He XQ; Wang ZH
    Curr Med Sci; 2022 Feb; 42(1):185-191. PubMed ID: 34669113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical comparison between neuroendocrine and endometrioid type carcinoma of the uterine corpus.
    Mei S; Gibbs J; Economos K; Lee YC; Kanis MJ
    J Gynecol Oncol; 2019 Jul; 30(4):e58. PubMed ID: 31074241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological characteristics and prognosis of uterine serous carcinoma: A SEER program analysis of 1016 cases.
    Han Y; Liu C
    J Obstet Gynaecol Res; 2021 Jul; 47(7):2460-2472. PubMed ID: 33870589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of Patients With Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer: A Taiwanese Gynecology Oncology Group (TGOG-2005) Retrospective Cohort Study (A STROBE-Compliant Article).
    Chen JR; Chang TC; Fu HC; Lau HY; Chen IH; Ke YM; Liang YL; Chiang AJ; Huang CY; Chen YC; Hong MK; Wang YC; Huang KF; Hsiao SM; Wang PH
    Medicine (Baltimore); 2016 Apr; 95(15):e3330. PubMed ID: 27082583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Adjuvant Modalities on Survival in Patients with Advanced Stage Endometrial Carcinoma: A Retrospective Analysis from a Tertiary Medical Center.
    Tai YJ; Hsu HC; Chiang YC; Chen YL; Chen CA; Cheng WF
    Int J Environ Res Public Health; 2019 Jul; 16(14):. PubMed ID: 31323767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study.
    Erickson BK; Najjar O; Damast S; Blakaj A; Tymon-Rosario J; Shahi M; Santin A; Klein M; Dolan M; Cimino-Mathews A; Buza N; Ferriss JS; Stone RL; Khalifa M; Fader AN
    Gynecol Oncol; 2020 Oct; 159(1):17-22. PubMed ID: 32709539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Risk factor analysis of lymph node metastasis in endometrial carcinoma combined with molecular types].
    Li LL; Li H; Li J; Zhang XB; Wang ZQ; Shen DH; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):733-741. PubMed ID: 37849254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.